YUCAIPA, Calif., Jan. 26, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:ITEC), an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally, announced today that it has received its first order from the National Guard Hospital based in Saudi Arabia.
According to the Department of Defense, from September of 2001 to November of 2007, more than 250,000 troops of the National Guard have been deployed in Afghanistan and Iraq alone, and in 2008 there were more than 460,000 soldiers in the National Guard.
The hospital consists of a 525 bed acute and tertiary medical care center providing health care service to SANG employees and their dependents. The services of the hospital are at a high level of professional standards as defined by the standards of the United States Joint Commission on the Accreditation of Health Care Organizations (JCAHO) and the Hospital Operation Standards.
The company has registered with the Central Contractor Registration (CCR) as the primary registrant database for the U.S. Federal Government. This registration will allow Ingen to sell its medical products to the National Guard. The National Guard of the United States is a reserve military force composed of state National Guard militia members or units under federally recognized active or inactive armed force service for the United States. The National Guard of the United States is administered by the National Guard Bureau, which is a joint activity under the Department of Defense.
For more information please visit:
About Ingen Technologies, Inc.
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.